Mebeverine HCl BP

Composition : Mebeverine Hydrochloride BP 135 mg Tablet.

Indication : Meverine is indicated for the symptomatic treatment of irritable bowel syndromme and other conditions usually included in this grouping such as: chronic irritable colon, spastic constipation, mucous colitis, spastic colitis. Meverine is also effective in colicky abdominal pain and cramps, persistent, non-specific diarrhoea (with or without alternating constipation) and flatulence. For the symptomatic treatment of gastrointestinal spasm secondary to organic diseases. Meverine-SR : Mebeverine Hydrochloride is indicated: For the symptomatic treatment of irritable bowel syndrome (IBS), other conditions include: Chronic irritable colon, Spastic constipation, Mucous Colitis, Colicky abdominal pain, Persistent non-specific diarrhoea.

Dosage and administration : Adults & Children over 10 years, 1 tablet 3 times daily, preferably 20 minutes before meals or as directed by a registered physician. Meverine-SR : Adults, elderly : 1 Capsule twice daily, preferably 20 minutes before meals. Or, as directed by the registered physician.

Use in pregnancy and lactation : No teratogenicity has been shown in animal experiments. However, the usual precautions concerning the administration of any drug during pregnancy should be exercised. Mebeverine dose not excrete in the breast milk after administering at therapeutic dose.

Packing :

Meverine : 5 x 10's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.